Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ELAN Elanco Animal Health
13.870-0.710-4.87%
Close
02/03 16:00 ET
13.8700.0000.00%
Post Mkt Price 02/03 16:15 ET
High
14.350
Open
14.280
Turnover
71.97M
Low
13.870
Pre Close
14.580
Volume
5.11M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
Elanco Animal Health Incorporated (NYSE:ELAN) will announce its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023. Elanco will also conduct a conference call on that day with the
S&P 500 Futures Drop In Premarket Trading; Snap, Electronic Arts Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Qualtrics International (XM) was up 8.9% in pre-mar
Analysts Offer Insights on Materials Companies: Lsb Industries (LXU), Nucor (NUE) and Elanco Animal Health (ELAN)
Morgan Stanley Adjusts Price Target on Elanco Animal Health to $19 From $20, Maintains Equalweight Rating
11:03 AM EST, 01/30/2023 (MT Newswires) -- Elanco Animal Health (ELAN) has an average hold rating and price target range of $12 to $20, according to analysts polled by Capital IQ. Price: 13.50, Change
What 4 Analyst Ratings Have To Say About Elanco Animal Health
Within the last quarter, Elanco Animal Health (NYSE:ELAN) has observed the following analyst ratings: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings00301Last 30D001001M Ago0000
Elanco Animal Health Is Maintained at Equal-Weight by Morgan Stanley
Elanco Animal Health Price Target Cut to $19.00/Share From $20.00 by Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $19
Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Equal-Weight and lowers the price target from $20 to $19.
Elanco Animal Health Inc (NYSE:ELAT) Short Interest Up 102.0% in January
Elanco Animal Health Inc (NYSE:ELAT – Get Rating) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totalling 10,100 shares, an incr
US Bancorp DE Has $178,000 Holdings in Elanco Animal Health Incorporated (NYSE:ELAN)
US Bancorp DE reduced its holdings in Elanco Animal Health Incorporated (NYSE:ELAN – Get Rating) by 33.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange
Company Overview
More
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
CEO： Mr. Jeffrey N. Simmons
Market： NYSE
Listing Date： 09/20/2018
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet